These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 29727385

  • 21. Oral l-ornithine-l-aspartate in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled trial.
    Alvares-da-Silva MR, de Araujo A, Vicenzi JR, da Silva GV, Oliveira FB, Schacher F, Oliboni L, Magnus A, Kruel LP, Prieb R, Fernandes LN.
    Hepatol Res; 2014 Sep; 44(9):956-63. PubMed ID: 24033861
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Efficacy of L-ornithine L-aspartate for minimal hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials.
    He Q, Mao C, Chen Z, Zeng Y, Deng Y, Hu R.
    Arab J Gastroenterol; 2024 May; 25(2):84-92. PubMed ID: 38403493
    [Abstract] [Full Text] [Related]

  • 24. L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
    Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, Sonika U, Dalal A.
    Hepatology; 2022 May; 75(5):1194-1203. PubMed ID: 34822189
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
    Kircheis G, Hilger N, Häussinger D.
    Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy.
    Sharma P, Sharma BC, Sarin SK.
    Neurol India; 2010 Apr; 58(2):220-4. PubMed ID: 20508339
    [Abstract] [Full Text] [Related]

  • 29. A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study.
    Fagan A, Gavis EA, Gallagher ML, Mousel T, Davis B, Puri P, Sterling RK, Luketic VA, Lee H, Matherly SC, Sanyal AJ, Stravitz RT, Patel V, Siddiqui MS, Asgharpour A, Fuchs M, Thacker L, Bajaj JS.
    J Hepatol; 2023 Feb; 78(2):312-321. PubMed ID: 36152764
    [Abstract] [Full Text] [Related]

  • 30. Covert hepatic encephalopathy: agreement and predictive validity of different indices.
    Montagnese S, Balistreri E, Schiff S, De Rui M, Angeli P, Zanus G, Cillo U, Bombonato G, Bolognesi M, Sacerdoti D, Gatta A, Merkel C, Amodio P.
    World J Gastroenterol; 2014 Nov 14; 20(42):15756-62. PubMed ID: 25400460
    [Abstract] [Full Text] [Related]

  • 31. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy.
    Sharma P, Sharma BC, Tyagi P, Kumar M, Sarin SK.
    Liver Int; 2009 Feb 14; 29(2):260-4. PubMed ID: 18710429
    [Abstract] [Full Text] [Related]

  • 32. Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.
    Sharma K, Pant S, Misra S, Dwivedi M, Misra A, Narang S, Tewari R, Bhadoria AS.
    Saudi J Gastroenterol; 2014 Feb 14; 20(4):225-32. PubMed ID: 25038208
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A critical analysis of studies assessing L-ornithine-L-aspartate (LOLA) in hepatic encephalopathy treatment.
    Soárez PC, Oliveira AC, Padovan J, Parise ER, Ferraz MB.
    Arq Gastroenterol; 2009 Feb 14; 46(3):241-7. PubMed ID: 19918694
    [Abstract] [Full Text] [Related]

  • 35. Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study.
    Wunsch E, Naprawa G, Koziarska D, Milkiewicz M, Nowacki P, Milkiewicz P.
    Ann Hepatol; 2013 Feb 14; 12(3):448-55. PubMed ID: 23619262
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P, Sharma BC, Sarin SK.
    Liver Int; 2009 Oct 14; 29(9):1365-71. PubMed ID: 19555401
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.